Phase II study of oral vinorelbine as neoadjuvant treatment in patients with locally advanced breast cancer older than 60 years

Trial Profile

Phase II study of oral vinorelbine as neoadjuvant treatment in patients with locally advanced breast cancer older than 60 years

Recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2011

At a glance

  • Drugs Vinorelbine (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 31 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top